- About Medicon Valley
- Science & research
- How can we help
Copenhagen Bio Science Park (COBIS)
COBIS is a hub for biotech organisations to grow and develop. The 12,000 square meters park host’s offices, international standard laboratory equipment, and conference and meeting space. It is home to 100 start ups, mid-size organisations and technology professionals with 400 employees in total.
Ideon Science Park
Ideon Science Park in Lund is the first Science Park founded in Sweden, and remains the largest in Scandinavia, with over 400 companies and about 10.000 people.
Krinova Science Park
Krinova Science Park is located adjacent to the Kristianstad University. It features well-equipped facilities and a number of outreach activities in order to encourage creativity in large and small companies alike. Krinova is uniquely placed to assist companies in developing their business models in environmental sciences, food sciences and human resources. The science park hosts 118 companies and 300 employees.
Medeon Science Park
Medeon in Malmö focuses entirely on life science: biotechnology, health sciences, medical technology and pharmaceuticals. The facilities provide support through tutoring and coaching in the industry standards. Medeon Science Park is home to 60 companies and 450 employees.
Medicon Village offers a unique environment for the growth of development intensive companies and knowledge base within the fields of biotechnology, pharmaceutical, medical devices, diagnostics and healthcare companies. Medicon Village hosts 120 companies and 1600 employees.
DTU Science Park
DTU Science and Technology Park hosts its high tech facilities in Lyngby and Hørsholm, Greater Copenhagen. It is located next to the technical university of Denmark (DTU) and the 19 research-intensive institutes within it. It is home to approx. 300 companies and 3400 employees.
Symbion is based in Copenhagen and creates a leading entrepreneurial environment. They currently have a large network of 450 companies with 2000 employees working on areas such as IT, life sciences and cleantech. Symbion work in partnership with Scion DTU and COBIS to create the best environment for science focused organisations.
Biofilms Malmö University
Biofilms Research Center for Biointerfaces is a translational research programme covering five research groups at Malmö University. They have a broad expertise, spanning from theoretical modelling to clinical sciences, and a long experience of working with industry.
Biotech Research and Innovation Centre (BRIC)
Disease-oriented basic research is the main focus of the research at BRIC. Their overall aim is to contribute to a basic understanding of how and why disease occurs, to discover new disease-related genes, and to identify new diagnostic markers, which are essential to provide more efficient treatment.
Read more about BRIC
Center for Healthy Aging
The Center for Healthy Aging is a network of research units, most of which are currently located at the University of Copenhagen. Center for Healthy Aging is a research center that studies how more people can have a healthy life and healthy aging. The approach to research is interdisciplinary and the center studies aging and aging processes from cell to society.
Center for Nanomedicine and Theranostics
The DTU Center for Nanomedicine and Theranostics develops advanced biomaterial technology and new medical inventions for diagnosing and treating severe diseases. The strong multidisciplinarity of the center allows for research in new biomedical technologies and evaluation of new treatment concepts in vitro and in vivo.
CREATE Health and MAD for Cancer
CREATE Health, the Strategic Centre for Translational Cancer research, and the MAD for Cancer Program is unique in its concept. It brings together several different facets of cancer biology from four university faculties into one multifocal approach focusing on personalised medicine for cancer.
The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark aims at developing new knowledge and technologies to help facilitate the transformation from the existing oil-based chemical industry to a more sustainable bio-based society in which chemicals are produced biologically.
Read more about DTU Biosustain
DTU Nanotech is a department at DTU, dedicated to conduct research, education and innovation within micro- and nanotechnology at the highest international level. They have four main research areas, one of which being Biomedical and Life science.
European Spallation Source ERIC and Max IV
The European Spallation Source ERIC (ESS) is a Partnership of 15 European nations committed to the goal of collectively building and operating the world’s leading facility for research using neutrons.
To succeed in its mission ESS relies on the expertise of its Partners from across Europe, and other areas around the globe. ESS has a large network of laboratories to exchange knowledge, personnel and experience with, and that in many cases will contribute directly to the project through In-Kind Contributions.
The facility is currently under construction in Lund, Sweden. However, when the ESS User Program begins in 2023, an estimated two to three thousand visiting scientists will come to ESS annually to perform experiments. Most users will be based at European universities and institutes, and others within Industry.
MAX IV Laboratory is the latest synchrotron facility inaugurated in June 2016. It is the brightest x-ray equipment available to scientists from academia and industry in the whole world. The 2 facilities can together bring the material science research on electrolyzers to the next level by making the invisible visible.
The X-rays will be used to understand, explain and improve the world around us. They will enable the study of materials that we use today and improve them beyond the performance that we know. The ESS will be of great importance in pre-clinical research within life science. Within the life science industry, neutrons and the neutron scattering techniques and methods are becoming a tool of choice in the understanding of drug delivery mechanisms and the early drug delivery and characterization.
When in operation ESS and MAX IV will be the world leading synchrotron facility. It is however not the first, as two other projects have been completed in Japan and the US. At the Japanese facility, SPring-8, scientists recently discovered what they believe could solve the myth of bacterial drug resistance.
Today antibiotics are commonly used to kill bacteria, but recently it has proven less effective due to drug resistance (Press release: New Protein Discovery Solves Myth of Bacterial Drug Resistance).
At the US facility Argonne National Laboratory, one of the most successful drugs were invented, stopping the progress of HIV. Today researchers study how viruses interact with cells. This information could help researchers to design drugs to block or reduce those interactions and hopefully cure HIV or extend more lives in the future.
LU Bio is a Lund University initiative in collaboration with private investors. It brings valuable life science research discoveries to investors who have the commercial know-how to start-up a successful business.
LU Innovation System
This is Lund University’s technology transfer office. LU Innovation System helps researchers commercialise their ideas.
Lund University Diabetes Centre (LUDC)
LUDC is a consortium of research groups at Lund University dedicated to unravelling the pathogenesis and treatment of diabetes mellitus.
The Lundbeck foundation have invested heavily in establishing many research centres at Copenhagen University. These cover a broad range of scientific areas, pertaining to different diseases. These research groups are; Asthma in Childhood, Biomembranes in Nanomedicine, Neuropsychiatric diseases, The Lundbeck Foundation Centre for Neurovascular Signaling, Brain Barrier research.
Lund Stem Cell Center
Lund Center for Stem Cell Biology and Cell Therapy focuses on stem cell and developmental biology of the central nervous and blood systems. It develops stem cell and cell replacement therapies within these organ systems as well as research into non-mammalian model systems.
Novo Nordisk Foundation Research Centres
DanStem (co founded by Danish Council for Strategic Research) - KU
DanStem, following investments from NovoNordisk and DCSR, is a research group focussed insulin producing beta cells and cancer research already located at the University of Copenhagen.
Novo Nordisk foundation Center for Metabolic research - KU
The Novo Nordisk Foundation Centre for Basic Metabolic Research is a centre of bringing scientific discoveries from the laboratory to the society in an effort to tackle some of today’s biggest challenges – diabetes and obesity. The close interdisciplinary collaboration between more than 100 skilled scientists enables more effective discovery strategies to prevent, control and, ultimately cure metabolic diseases.
Novo Nordisk Foundation Center for Protein research – KU
The Novo Nordisk Foundation Centre for Protein Research was established in 2007 at the Faculty of Health and Medical Sciences, University of Copenhagen, to promote basic and applied discovery research on human proteins of medical relevance. The centre comprises a wide range of expertise and skills within its research programs spanning disease systems biology, proteomics, high-throughput protein production and characterisation, chemical biology, disease biology, and protein therapeutics.
The Center for Translational Neuroscience – KU
The centre for Translational Neuroscience focuses on the development of new approaches for treating neurological diseases, primarily using cell and gene therapy. The focus is on using these technologies to mobilise endogenous stem and progenitor cells of the adult brain and spinal cord, as a means of structural repair.
CAPNOVA is an investment and development company that turns the ideas of innovative entrepreneurs into successful businesses by investing governmental, regional and own venture capital.
Ideon Innovation is one of Europe’s most powerful incubator programmes. It helps entrepreneurs and innovators from academia, research institutes and industry transform their ideas into competitive businesses.
Read more about Ideon Innovation
Started in 2002, PULS is the bridge between innovators and the pharmaceutical industry ensuring the optimisation of value in life science. It acts as an incubator and investor for projects by engaging early with innovators to attain an optimal IP platform and high quality development throughout the process.